We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
Harmed patients deserve answers, not assumptions. We explore APC's Scott Brunner's thoughts.
State updates on the latest bills and policy impacting compunding pharmacists.
The Department of Health and Human Services' Office of Inspector General, announced a study examining how well the FDA has been overseeing GLP-1 ...
FDA schedules a peptide PCAC meeting , but what does that actually mean for compounders? APC dives in.
.jpg)
A recent Washington Post opinion highlights a serious patient outcome tied to a compounded weight-loss drug. The case is concerning and deserves ...
.png?width=410&height=320&name=image-container%20(1).png)
.png?width=410&height=320&name=image-container%20(2).png)
.png?width=411&height=320&name=image-container%20(3).png)
.png?width=410&height=320&name=image-container%20(4).png)
.png)
.png?width=17&height=16&name=folder%20(1).png){kind=small}
%20Pharma-GS.png)
